# A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

> **NCT06321510** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 29 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06321510
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321510, "A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06321510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*